for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-AstraZeneca Says FDA Authorises Restart Of COVID-19 Vaccine Trial in U.S.

Oct 23 (Reuters) - AstraZeneca PLC:

* FDA AUTHORISES RESTART OF COVID-19 AZD1222 VACCINE US PHASE III TRIA

* FOOD AND DRUG ADMINISTRATION (FDA) AUTHORISED RESTART OF TRIAL IN US

* FDA REVIEWED ALL SAFETY DATA FROM TRIALS GLOBALLY AND CONCLUDED IT WAS SAFE TO RESUME TRIAL. Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up